Search for: "MERCK & CO., INC. "
Results 161 - 180
of 674
Sorted by Relevance
|
Sort by Date
24 Feb 2012, 2:08 pm
Merck & Co., Inc., 09 Civ. 6948 (JFK), is scheduled for trial on September 10, 2012. [read post]
28 Mar 2011, 1:57 pm
610 Cases Were In Federal Court NuvaRing MDL And 110 Complaints Filed In New Jersey State Court (Posted by Tom Lamb at DrugInjuryWatch.com)The following information about the number of NuvaRing lawsuits that had been filed before January 2011 comes from page 129 of the Merck & Co., Inc. [read post]
3 Apr 2019, 5:15 am
Merck & Co. 890 F.3d 1231(Fed. [read post]
14 Mar 2014, 1:05 pm
” Merck & Co., Inc. v. [read post]
16 Apr 2007, 5:38 am
In re Merck & Co., Inc., Securities, Derivative & "ERISA" Litig., ___ F.Supp.2d ___ (D. [read post]
10 Jan 2014, 8:10 am
See In re Merck & Co. [read post]
27 Dec 2012, 7:42 am
See In re Keller, 642 F.2d 413, 426 (CCPA 1981)(finding that one cannot show nonobviousness by attacking references individually where the rejections are based on combinations of references); see also In re Merck & Co., Inc., 800 F.2d 1091, 1097 (Fed. [read post]
27 Dec 2012, 7:24 am
See id. at 426; In re Merck & Co., Inc., 800 F.2d 1091, 1097 (Fed. [read post]
16 Oct 2013, 5:55 am
See In re Merck & Co., Inc., 800 F.2d 1091,1097 (Fed. [read post]
20 Jun 2013, 9:05 am
In re Merck & Co., 800 F.2d 1091, 1097 (Fed.Cir. 1986); In re Keller, 642 F.2d 413, 425 (CCPA 1981). [read post]
24 Dec 2013, 5:32 am
In re Merck & Co., Inc. 800 F.2d 1091, 1097 (Fed. [read post]
25 Jan 2016, 5:00 am
Merck White Lead Co. v. [read post]
6 Apr 2018, 10:25 am
Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc. [read post]
21 Oct 2013, 1:57 pm
Merck & Co., 948 A.2d 587, 595 (N.J. 2008) (citations omitted).14 Bailey v. [read post]
19 Aug 2008, 10:35 pm
Vioxx came on the market in June 1999, after rival Pfizer Inc.'s Celebrex. [read post]
19 Aug 2008, 10:35 pm
Vioxx came on the market in June 1999, after rival Pfizer Inc.'s Celebrex. [read post]
26 Apr 2007, 2:32 am
BusinessWeek notes another Congressional hearing on patent reform will occur on April 26, with testimony from Kevin Sharer, chief executive of biotech company Amgen Inc.; Anthony Peterman, patent counsel for computer manufacturer Dell Inc.; and Gary Griswold, president and chief counsel of intellectual property at 3M Co.Dell Inc. is a member of the Coalition for Patent Fairness, comprised mainly of IT companies strongly seeking patent reform (including Amazon.com, Apple,… [read post]
15 Apr 2013, 7:10 am
See In re Merck & Co., Inc., 800 F.2d 1091, 1097 (Fed. [read post]
29 Sep 2008, 12:01 pm
” In re Merck & Co., Inc. [read post]
9 Nov 2007, 4:53 am
VIOXX(r) Product Liability Lawsuits Agreement Provides for $4.85 Billion PaymentWHITEHOUSE STATION, N.J., Nov. 9, 2007 - Merck & Co., Inc. today announced that it has entered into an agreement with the law firms that comprise the executive committee of the Plaintiffs' Steering Committee of the federal multidistrict VIOXX litigation as well as representatives of plaintiffs' counsel in state coordinated proceedings to resolve state and federal myocardial… [read post]
